Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5–10% of patients are unresponsive to colchicine. Aim of this …
worldwide. Approximately 5–10% of patients are unresponsive to colchicine. Aim of this …
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
F EROGLU, N Besbas… - RHEUMATOLOGY …, 2015 - avesis.hacettepe.edu.tr
Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
FK Eroglu, N Beşbaş, R Topaloglu, S Ozen - Rheumatology International, 2015 - infona.pl
Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5–10% of patients are unresponsive to colchicine. Aim of this …
worldwide. Approximately 5–10% of patients are unresponsive to colchicine. Aim of this …
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
FK Eroglu, N Beşbaş, R Topaloglu… - Rheumatology …, 2015 - hero.epa.gov
Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
[PDF][PDF] Treatment of colchicine‑resistant Familial Mediterranean fever in children and adolescents
FK Eroglu, N Besbas, R Topaloglu, S Ozen - 2015 - researchgate.net
Accepted: 14 May 2015© Springer-Verlag Berlin Heidelberg 2015 (4–60 months). Nine
patients responded to treatment at the third month, but four of them switched to canakinumab …
patients responded to treatment at the third month, but four of them switched to canakinumab …
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
FK Eroglu, N Besbas, R Topaloglu… - Rheumatology …, 2015 - search.proquest.com
Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
FK Eroglu, N Beşbaş, R Topaloglu… - Rheumatology …, 2015 - europepmc.org
Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
FK Eroglu, N Beşbaş… - Rheumatology …, 2015 - pubmed.ncbi.nlm.nih.gov
Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
F Eroglu, N Beşbaş, R Topaloglu… - Rheumatology …, 2015 - search.ebscohost.com
Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …
worldwide. Approximately 5-10% of patients are unresponsive to colchicine. Aim of this …